Skip to main content
Paradigm Biopharmaceuticals Limited (ASX:PAR)
Australia flag Australia · Delayed Price · Currency is AUD
0.2450
0.00 (0.00%)
Sep 18, 2026, 4:10 PM AEST

ASX:PAR Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Market Capitalization
1539611989279224
Market Cap Growth
33.11%-18.75%32.94%-67.97%24.43%-53.57%
Enterprise Value
146919456195170
Last Close Price
0.240.170.300.260.960.93

Price Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Forward PE
-14.0514.0514.05--
PS Ratio
-----2829.64
PB Ratio
44.2227.805.613.605.205.30
P/TBV Ratio
59.8437.625.724.095.505.70

EV Ratios

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
EV/Sales Ratio
-----2142.53

Financial Efficiency

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Debt / Equity Ratio
2.162.1600.010.010.02
Net Debt / Equity Ratio
-2.29-2.29-0.79-0.71-1.04-0.92
Net Debt / EBITDA Ratio
0.130.130.730.270.940.82
Net Debt / FCF Ratio
0.180.181.050.271.241.21
Asset Turnover
-----0.00
Quick Ratio
1.071.077.177.124.855.93
Current Ratio
1.101.107.467.514.896.02
Return on Equity (ROE)
-456.96%-456.96%-81.66%-149.69%-108.16%-65.10%
Return on Assets (ROA)
-138.75%-138.75%-55.11%-85.28%-63.78%-44.22%
Return on Capital Employed (ROCE)
-1540.60%-1540.60%-109.40%-260.30%-111.20%-111.80%

Yields

Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Earnings Yield
-62.13%-58.38%-15.80%-65.74%-18.61%-17.51%
FCF Yield
-28.46%-45.27%-13.46%-73.81%-16.20%-14.37%
Buyback Yield / Dilution
-17.66%-17.66%-7.23%-17.43%-7.34%-1.21%